Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.2.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-937.283Japan
XCZORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-937.283Japan
MB.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-937.283Japan
BQ.1.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-937.283Japan
JN.1.4.6ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-937.283Japan
FL.39.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-937.283Japan
GK.1.11.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
B.1.274NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
B.1.515NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
B.1.258.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
B.1.167NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
B.1.444NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
B.1.420NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
B.1.160.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-941.915South Korea
BA.5.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-974.332France
BA.2.75ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-974.332France
BA.5.2.44ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-974.332France
B.1.160.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-982.809US
XCHSWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1087.3Japan
XCH.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1087.3Japan
B.1.1.74NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-1125.12Thailand
B.1.277NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-1125.12Thailand
B.1.595.3SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-1147.45China
EK.4SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-1147.45China
B.1.177.83SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-1147.45China
B.1.258.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-1211.7China
AP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
B.1.1.515NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
HC.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
B.1.1.70NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
MK.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
BA.1.1.5SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
EK.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
HK.16SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
JN.1.1.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
CM.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
BQ.1.1.67SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
BE.1.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
XBB.1.11.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
FL.1.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
XBF.7.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
B.1.1.161SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
BN.1.3.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
GA.8SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
BN.1.2.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
XANSWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
XBC.1.6.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
BN.1.5SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
BA.2.75.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
BQ.1.1.19SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used